Navigation Links
Waterville Investment Research Profiles Impact Medical Solutions
Date:10/19/2007

HUNTINGTON BEACH, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Impact Medical Solutions, Inc. (OTC Bulletin Board: IMSU), a medical technology company, announced today that it has signed an agreement with Waterville Investment Research of New York to profile the Company in an extensive research report for the investment community. The report is now available at http://www.watervilleresearch.com/companies/medical/244-1.html .

Impact Medical Solutions ("Impact") is a medical technology company. The Company's first product is a non-invasive medical device based on a proprietary technology called Muscle Pattern Recognition (MPR). MPR has been developed as a unique clinical tool for people suffering from back pain relating to musculoskeletal function. MPR analyzes patterns of muscle recruitment during the performance of specific body postures and provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injuries and illness.

"Waterville Investment Research provides fundamental Wall Street investment data and research on Small-Cap public companies," said Wayne D. Cockburn, President and CEO of Impact Medical Solutions. "The broad exposure they provide through their large global network and on-line research database is an excellent way for us to begin reaching out to the investment community to raise the awareness of our company and the overall growth prospects for our business."

Michael Sweeney, Senior Partner at Waterville Investment Research commented, "We look forward to our continued coverage of Impact Medical Solutions as the Company moves to product launch. On a personal level, as one who suffers from occasional back pain, I also look forward to working with Impact on a clinical level."

About Impact Medical Solutions

Impact Medical Solutions (OTCBB: IMSU) is engaged in the research and commercial development of healthcare information systems and technology. To date, it has focused on developing a proprietary platform called Muscle Pattern Recognition (MPR), a unique clinical tool for the kinesiologic analysis of muscle function. MPR analyzes patterns of muscle recruitment and provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injuries and illness.

Forward-Looking and Cautionary Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that reflect management's current views and estimates regarding future market conditions, company performance and financial results, business prospects, new strategies, the competitive environment and other events. You can identify these statements by the fact that they use words such as "anticipate," "believe," "estimate," "expect," "intend," "project," "plan," "outlook," and other words and terms of similar meaning. These statements involve a number of risks and uncertainties that could cause actual results to materially differ from the potential results discussed in the forward-looking statements. Among the factors that could cause actual results and outcomes to differ materially from those contained in such forward-looking statements are the following: general economic conditions, acquisitions and development of new businesses, divestitures, product availability, sales volumes, pricing actions and promotional activities of our competitors, profit margins, weather, changes in law or regulations, foreign currency fluctuation, availability of suitable real estate locations, our ability to react to a disaster recovery situation, and the impact of labor markets and new product introductions on our overall profitability. A further list and description of these risks, uncertainties and other matters can be found in the company's annual report and other reports filed from time to time with the Securities and Exchange Commission, including, but not limited to, Impact Medical Solutions, Inc.'s Annual Report on Form 10-K filed with the SEC on April 17, 2007. Impact Medical Solutions cautions that the foregoing list of important factors is not complete and assumes no obligation to update any forward-looking statements that it may make.

For further information about Impact Medical Solutions, please visit: http://www.impactmedsol.com


'/>"/>
SOURCE Impact Medical Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. China Doubles Its Investment In AIDS/HIV Treatment.
2. Biocon To Raise Its Investment In Scotland
3. Cocoa Treats: Chocolates, as a Health Investment? Chew on this!
4. Varicose Vein Treatments Turn Out To Be A Viable Health Investment
5. WHO calls for big investment in tests for TB
6. China Opens Doors For Foreign Investments In Hospitals Care System
7. Fidel Castro Appeals for Investment in Health Rather Than in Arms
8. Kidney Stones - Interesting New Research implicates bacteria as its cause
9. Stem cell research- now Nobel Laureates join the debate
10. Researchers urge caution in using ear tube surgery
11. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ANGELES (PRWEB) , ... October 12, 2017 , ... ... Parsa Mohebi Hair Restoration, has recently contributed a medical article to the newly ... on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: